Veterinary Medicines

CEFALEXINA VIRBAC 375 mg/jeringa suspensión intramamaria

Authorised
  • Cephalexin benzathine
Download as PDF

Product identification

Medicine name:
CEFALEXINA VIRBAC 375 mg/jeringa suspensión intramamaria
Active substance:
  • Cephalexin benzathine
Target species:
  • Cattle (dry cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cephalexin benzathine
    375.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dry cow)
      • Meat and offal
        4
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2743 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."